The market for IVD currently stands at $69.2 billion dollars
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry.
What is the Size of the 2019 IVD Market?
How fast will the market grow?
What companies stand to gain?
It is poised for growth over the next five years, improved growth from the last edition of the report. There are hundreds of companies competing in the market in some form and scores of large multi-test players.
This 2,000-page report provides in vitro diagnostics market size estimates and projections:
2000-Page Report Based on Vendor Reporting, Interviews, Vendor Activities
Authored by Veteran IVD Analysts with Industry Knowledge
12 Detailed Market Chapters with 2019 Market Estimate
Relevant Segmentation for Test Business Planners, Investors, New Entrants, and Other Market Watchers
Where is IVD Heading? - Market Segment Projections to 2024
What's Behind the Growth and Declines? - Market Numbers and Analysis
Regional Breakouts Including Country IVD Markets
Sections on China, Europe, Japan, and The United States IVD Markets
Macro Analysis of Major Trends
Superior Company Profiles of Top Tier Companies and Hundreds of Smaller Concerns
Used by Major IVD Firms for Business Planning
Coverage of Trends and Market Estimates for Essential IVD Segments: Clinical Chemistry, Point-of-Care, Molecular, Infectious Disease, Histology and More.
In vitro, diagnostic testing costs little to the healthcare system and contributes much to clinical practice. For some time this has been stated as educated conjecture; a recent study of U.S and German physicians offer proof. The study found that 66% of clinical decisions made were based on a diagnostic test, while the costs of those tests were just 2.3% of healthcare expenditure (Rohr U., Binder C, PLoS One. 2016).
When the cost-effectiveness of in vitro diagnostic testing is then considered along with beneficial effects on treatment outcomes, therapy choices, and hospital management, there should be little surprise about the amount of interest in IVDs and the amount of activity in the market for them.
The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2024 for defined segments of the IVD market and various sub-segments, including:
Clinical Chemistry and Core Lab Markets: General Chemistries, Blood Gases, Urinalysis, Immunos run on Workstations
Point-of-Care Testing (POC): Professional and Self-Testing, Fertility, Colon Cancer, HbA1c POC, Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OT
Glucose Testing: Meters, Professional Testing, Continuous Glucose
Substance Abuse Testing (Employment Screening, Criminal Justice, Critical Care - Traditional POC)
Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
For each of the listed in vitro diagnostics market segments, 2019 in vitro diagnostics market size, 2024 projection, and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers' product innovations. The market data is put into a context with real-world industry and medical practice trends.
The IVD Market Opportunity by Country
The in-vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 12th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers' product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included.
Who's In The Market? Who's Winning?
The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that the publisher has in the in vitro diagnostics market is evident in its tiering and segmentation of companies.
Key Topics Covered
The Global Picture for In Vitro Diagnostic Markets
Company and Industry Trends
The Core Lab
Microbiology and Virology
Blood Banking Services
Histology and Cytology
Company Profiles: The Top Tier
Company Profiles: The Second Tier
Company Profiles: Blood Bank Specialists
Company Profiles: Coagulation Specialists
Company Profiles: Core Lab and Other Companies
Company Profiles: CTC & Liquid Biopsy Test Providers
Company Profiles: Hematology (Cell Analysis) Specialists
Company Profiles: Histopathology Specialists
Company Profiles: Immunoassay Specialists
Information Technology Specialists in In Vitro Diagnostics
Company Profiles: Microbiology Specialists
Company Profiles: Molecular Test Specialists
Company Profiles: Point of Care Test Specialists
Company Profiles: Prenatal Test Service Providers
Company Profiles: Quality Control & Sample Pretreatment Specialists
Test Service Providers
A. Menarini Diagnostics
AB SCIEX Pte Ltd
Abingdon Health Ltd.
Accelerate Diagnostics, Inc.
Advanced Biological Laboratories, S.A. (ABL)
Advanced Cell Diagnostics (ACD)
Amoy Diagnostics Co. Ltd.
Applied Spectral Imaging Inc. (ASI)
ArcDia International Oy Ltd.
Atlas Genetics Ltd. (Binx Health)
Beckman Coulter, Inc. / Danaher
Becton, Dickinson and Company (BD)
BGI Genomics (formerly Beijing Genome Institute)
BioFire Diagnostics, LLC. (acquired by bioMrieux)
BioGenex Laboratories, Inc.
Biohit Oyj (Biohit Healthcare)
Bio-Rad Laboratories, Inc.
Bruker BioSciences Corporation
Chembio Diagnostic Systems, Inc.
COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
Corgenix Medical Corporation
Cynvenio Biosystems (LungLife AI)
Dell Technologies Inc.
Desktop Genetics Ltd.
Diagnostica Stago, S.A.S.
DNA Electronics Ltd (DNAe)
Eiken Chemical Co., Ltd
EKF Diagnostics Holdings Plc
ELITech Group S.A.S.
Enzo Biochem Inc.
ERBA Diagnostics, Inc.
Exosome Diagnostics, Inc.
Fast Track Diagnostics (acquired by Siemens Healthineers)